3.5. After Intervention with the PPARγ Agonist, Vascular Endothelial Dysfunction in Hypercholesterolemic Rats Alleviated, Vascular MPO Activity Decreased, and the NO/cGMP/cGK Signaling Pathway Improved. Here, PPARG is linked to endothelial dysfunction.